Newsletter Subject

Misoprostol Alone in Self-Managed Abortion Is Highly Effective

From

medpagetoday.com

Email Address

daily.headlines@broadcaster3.medpagetoday.com

Sent On

Fri, Oct 27, 2023 10:52 PM

Email Preheader Text

Daily Headlines Friday, October 27, 2023 Today's Top Stories for {NAME} THE BREAK ROOM CME SPOTLIGHT

[MEDPAGE TODAY]( Daily Headlines Friday, October 27, 2023 Today's Top Stories for {NAME} [OB/GYN]( [Misoprostol Alone in Self-Managed Abortion Is Highly Effective]( [PUBLIC HEALTH & POLICY]( [How Can the U.S. Achieve Universal Coverage? With a Two-Part Plan, Expert Says]( [PULMONOLOGY]( [COVID Upended Bronchiolitis Admission Patterns in Kids]( THE BREAK ROOM [Wordectomy: Guess Today’s Medical Condition]( CME SPOTLIGHT [Evaluating the Cause of Anemia: Diagnosis and Management of Myelodysplastic Syndromes]( [NEUROLOGY]( [Subcutaneous Alzheimer's Drug May Be on the Horizon]( [MEETING COVERAGE]( [EP Study During TAVR Offers Better Prediction of Late Conduction Disturbances]( THE BREAK ROOM [Play Today’s Wordosis]( ADVERTISEMENT [OPINION]( [A Forensic Mission Following the Hamas Terrorist Attacks in Israel]( CME SPOTLIGHT [Advancing Care of Patients With Sickle Cell Disease]( [PUBLIC HEALTH & POLICY]( [Private Equity, For-Profit Interests Hurt Medicine, Conference Speakers Say]( [HOSPITAL-BASED MEDICINE]( [Skipping Hand Hygiene Before Donning Gloves May Be Just as Safe, Trial Suggests]( [MEETING COVERAGE]( [Emerging Biomarkers of Multiple Sclerosis in Blood and CSF]( CME SPOTLIGHT [Watch and Wait or Initiate: Providing Timely Access to Novel Therapies for Chronic Lymphocytic Leukemia]( [MEETING COVERAGE]( [Tricuspid Valve Replacement Safe, Effective in Pivotal Trial]( [GASTROENTEROLOGY]( [Novel Drug OK'd for Ulcerative Colitis]( [OPHTHALMOLOGY]( [Diabetic Eye Screening: Reducing Frequency May Raise Retinal Risks]( CME SPOTLIGHT [Advancing the Integration of CAR T-Cell Therapy in Community Oncology Centers: A Transformative Quality Improvement Initiative at a Large Community-Based Network]( [OPINION]( [The Administrator on Big Changes in CMS]( [MEETING COVERAGE]( [Mitral Valve TEER Device 'Horse Race' Draws Even Closer]( [CLINICAL CHALLENGES]( [Clinical Challenges: Vaccinating Kids With Needle Phobia]( CME SPOTLIGHT [Advancing cTTP Care Through Integration of the Latest Clinical Evidence]( [ONCOLOGY/HEMATOLOGY]( [Soap to Fight Skin Cancer; $1,000 Early Cancer Detection Test; FDA Approval in MDS]( [NEUROLOGY]( [Novel Corticosteroid Approved for Rare Disease]( [OPINION]( [The Hidden Curriculum: Mentorship and Mindfulness in Medicine]( CME SPOTLIGHT [Hitting the Mark? Targeted Antibody-Based Therapy for Diffuse Large B-Cell Lymphoma]( [PODCASTS]( [MedPod Today: COVID Rundown; Shady Medicare Advantage Ads; RIP 'Excited Delirium']( # Weekly Survey [Should Eisen Have Been Fired?]( Some in academia have raised concerns that Michael Eisen, PhD, [lost his job at eLife]( over his social media posts about the Israel-Hamas conflict[VOTE >]( Meeting Coverage Can't get away? MedPage Today brings you extensive coverage of more than 80 meetings in a wide range of specialties. [SEE ALL STORIES >]( Got a news tip? MedPage Today offers several ways to provide information to our journalists securely and confidentially. [LEARN MORE >]( [EVERYDAY HEALTH]( © 2023 MedPage Today, LLC. MedPage Today is among the federally registered trademarks of MedPage Today, LLC, and may not be used by third parties without explicit permission. You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address: {EMAIL} [Manage Email Preferences]( | [Unsubscribe](lst=NL_Daily_DHE?xid=nl_mpt_DHE_2023-10-27&eun=g1020308d0r) | [Terms of Use]( | [Privacy Policy]( Technical Questions: feedback@medpagetoday.com 114 5th Avenue, 15th Floor New York, NY 10011

Marketing emails from medpagetoday.com

View More
Sent On

08/12/2024

Sent On

08/11/2024

Sent On

07/11/2024

Sent On

07/11/2024

Sent On

06/11/2024

Sent On

04/11/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.